Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Growth stocks coverage continues on proactiveinvestors.com Go there →

Company

Memphasys Ltd

ASX:MEM

Memphasys Limited is an Australian-based reproductive biotechnology company commercialising the Felix™ System - a patented sperm separation technology that isolates the most viable sperm cells for human assisted reproductive technology (ART).  The Felix™ System is CE marked, included in the Australian Register of Therapeutic Goods (ARTG), and registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA). 

4 stories